Merk Thankful to US FDA for approval of Vorapaxar

Vorapaxar is the company’s investigational antiplatelet medicine for the reduction of atherothrombotic events, when added to standard of care, in patients with a history of heart attack and no history of stroke or transient ischemic attack. “There are approximately 7.6 million Americans who have survived a heart attack. Each year, about 190,000 of them have…

Read More

AstraZeneca and Bristol- Myers decides to help American diabetes

The two companies allies to grant around $5 million to aid American diabetics association.The innovative research initiative provides resources and support for a new generation of diabetes researchers and is designed to generate exciting discoveries through excellence, innovation, collaboration and radical thinking. “The AstraZeneca/Bristol-Myers Squibb Diabetes Alliance recognizes the need for a broader approach to…

Read More

FDA disappoint Genzyme over Lemtrada..

US FDA gave a complete response letter to Genzyme over Lemtrada, which means their application for its multiple scleroisis drug is been rejected. According to FDA, Genzyme was not able to provide sufficent advantage of the drug over its side effects! Lemtrada is approved in the European Union, Canada, and Australia, and additional marketing applications…

Read More

Cell culture media, gene modulation and magnetic beads businesses worth $1.06bn

GE Healthcare has finalized a deal with Thermo Fisher Scientific  to acquire its HyClone cell culture media and sera, and gene modulation and magnetic beads businesses. Reportedly, this transaction will allow GE   to expand its offering of end-to-end technologies for cell biology research, cell therapy and for the discovery and manufacturing of new medicines, vaccines and diagnostics in…

Read More

TEVA- GRA! (Pfizer gives Teva viagra!)

  Pfizer famous drug for erectile dysfunction Viagra patent expires by 2020! Teva will be allowed to market the generic version of Viagra by 2017. this process is on its way to get approved by US FDA. Teva in exchange will be paying royalty to Pfizer. It seems to be a great deal for both…

Read More

Insulin Pills – Boon for diabetic patients

It took scientists really long time, still it is going to be one of the most awaited product for all diabetic patients. Patients will not have to puncture themselves with injections. Scientists have made a new development for creating insulin pills! It is published in the ACS journal Biomacromolecules.

Read More